Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Legend Capital

Legend Capital

Established in 2001, Legend Capital is a venture capital firm based in China.

Legend Capital is a private equity based venture capital firm headquartered in Beijing. The firm was founded in 2001 as a spinout of Legends Holdings. The firm invests primarily in early stage funding rounds of United States and China based companies. It targets the IT, consumer goods, clean technology, health care, equipment manufacturing and digital services sectors.

In 2017 it was reported that the company had invested in 450 companies or which 70 had gone on to IPOs on international markets. It was reported in 2019 that the company managed both USD and RMB based funds that have combined assets under management (AUM) valued at ¥45 billion.

In February 2012, the company rebranded as "Junlian".

Timeline

May 18, 2021
Legend Capital closes LC Healthcare Continued Fund I, L.P., having raised US $270,000,000 for a secondary transaction that involves healthcare portfolios of two older vintage funds.
April 2001
Legend Capital was founded.

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Legend Capital
May 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- Legend Capital announced today that the firm has closed LC Healthcare Continued Fund I, L.P., having raised US$270 million for a secondary...
Liya Su
December 10, 2020
DealStreetAsia
GL Ventures and Legend Capital also participated.
Liya Su
November 29, 2020
DealStreetAsia
Kunya Medical has raised $15 million in its Series C round led by Haier Biomedical.
Kim Tong-Hyung
October 14, 2019
CTVNews
South Korea's justice minister resigned Monday, citing the political burden of an investigation into alleged financial crimes and academic favours surrounding his family, a scandal that has rocked Seoul's liberal government and spurred huge protests.

References

Golden logo
By using this site, you agree to our Terms & Conditions.